Targeting deadly lung-scarring disease, Peninsula biotech snares $100M crossover round By: San Francisco Business Times via Business Journals March 03, 2020 at 09:24 AM EST The new funding has set the table for the South San Francisco biotech to serve up an IPO. Read More >>
